← Oncology Approval Tracker

FDA DECISION ·

Cyclophosphamide Injection

cyclophosphamide · AuroMedics Pharma

FDA approvalNew formulationMultiple hematologic and solid malignancies
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Concentrated injectable cyclophosphamide under a 505(b)(2) NDA for specified oncology uses, including lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, and ovarian, retinal and breast malignancies.

LAMPGEN ANALYSIS

Why it matters

The action adds a liquid presentation of an established alkylating agent across existing cancer uses.

What research teams should watch

Distinguish the concentrate from powder products in pharmacy verification and record indication and preparation instructions.

PRIMARY RECORDS

Sources